Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Chapter 9.2
GLP-1 agonists are peptides that mimic the natural GLP-1 hormone present in the body to release insulin and suppress the release of glucagon in response to eating, thereby lowering blood sugar
- Dihexa is a cGMP research product available in both 5MG 60 capsule and 10MG/ML 30ML liquid prep formats, designed for controlled laboratory investigations involving HGF/c-Met pathway research, synaptogenic signaling models, neurotrophic pathway biology, neuronal connectivity studies, cognitive pathway research, dendritic spine formation models, and central nervous system cellular response systems
Gut Health and Inflammatory Bowel Disease (IBD) Research suggests GHK-Cu may reduce inflammation in the gut and promote intestinal healing, making it a potential therapeutic agent for conditions like Crohn's disease and ulcerative colitis
The delayed-release capsule design is intended to protect probiotic viability through stomach acid, delivering the formula to the intestines where L-cells are concentrated
Sustainable Appetite Control GLP 1 therapy reduces overeating by addressing appetite signals at a metabolic level
US$ 22.72
US$ 23.65
US$ 26.89
US$ 20.43
US$ 26.20
US$ 26.19
US$ 20.70
